Policy Brief: Transitioning to an Optimal Paediatric ARV Formulary - Implementation Considerations

Laws and Policies - Released in 2018

Antiretroviral treatment (ART) optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment.

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal ARV medicines and dosage forms become available.

Organizations

  • World Health Organization (WHO)